DisperseBio
A natural mechanism that blocks biofilm formation on various natural surfaces including the human body.
DisperseBio, founded in 2021 by Dr. Amir Zlotkin, is tackling the widespread industrial problem of biofilm formation. The company is headquartered in Tel Aviv, Israel, and operates within the specialty chemicals and industrial technologies sectors. Dr. Zlotkin, now the company's CTO, leveraged 15 years of research into a biological mechanism observed in marine life like jellyfish that naturally prevents biofilm accumulation. This research culminated in five patent families and the creation of DisperseBio's core technology. Since mid-2025, the company has been led by CEO Bruno Grandsard, a global business leader with experience in finance, operations, and climate tech.
The company's core product is a nature-inspired, non-toxic coating that prevents and disrupts biofilm formation without using harmful antimicrobial chemicals. This technology is centered on a synthetic peptide that activates a microbe's own self-degrading enzymes, breaking down the protective matrix that allows biofilms to adhere to surfaces. This approach avoids killing the microorganisms, which can lead to resistance. The solution is positioned as an eco-friendly and cost-effective alternative to traditional anti-fouling methods. A key selling point is its efficiency; reportedly, just two grams of the agent can protect a 2,000 square meter wet surface area, such as the hull of a ship.
DisperseBio operates on a B2B model, targeting a range of industries where biofilm and biofouling cause significant operational and financial issues, including increased energy consumption and equipment damage. Key markets include maritime industries (shipping, aquaculture, offshore oil & gas), seawater reverse osmosis (SWRO) desalination, industrial water-cooling systems, and agriculture. By addressing these challenges, the company aims to improve energy efficiency and reduce production losses for its clients. DisperseBio has received $200K in pre-seed funding from investors including IndieBio, SOSV Investments, Blue Launchpad, and HiCenter, and is currently generating revenue.
Keywords: biofilm management, biofouling prevention, non-toxic coatings, synthetic peptides, maritime industry, desalination, water treatment, sustainable chemicals, anti-fouling, microbial contamination, industrial biotechnology, climate tech, energy efficiency, corrosion control, aquaculture, asset protection, green technology, marine biology, microbial dispersion, water systems